BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28718694)

  • 1. Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval length.
    Ammann EM; Shanafelt TD; Wright KB; McDowell BD; Link BK; Chrischilles EA
    Leuk Lymphoma; 2018 Mar; 59(3):643-649. PubMed ID: 28718694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Ammann EM; Shanafelt TD; Larson MC; Wright KB; McDowell BD; Link BK; Chrischilles EA
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):e11-e25. PubMed ID: 28802891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
    Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
    Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Richter's transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database.
    Elnair R; Ellithi M; Kallam A; Shostrom V; Bociek RG
    Ann Hematol; 2021 Oct; 100(10):2513-2519. PubMed ID: 34279675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia.
    Martínez-Trillos A; Pinyol M; Delgado J; Aymerich M; Rozman M; Baumann T; González-Díaz M; Hernández JM; Alcoceba M; Muntañola A; Terol MJ; Navarro B; Giné E; Jares P; Beà S; Navarro A; Colomer D; Nadeu F; Colado E; Payer AR; García-Cerecedo T; Puente XS; López-Otin C; Campo E; López-Guillermo A; Villamor N
    Leuk Lymphoma; 2018 Oct; 59(10):2318-2326. PubMed ID: 29115891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin lymphoma transformation of chronic lymphocytic leukemia-A real life data from the Polish Lymphoma Research Group.
    Drozd-Sokołowska J; Zaucha JM; Żółtak T; Jamroziak K; Grzybowska-Izydorczyk O; Witkowska M; Waszczuk-Gajda A; Kaźmierczak M; Szczepaniak A; Subocz E; Knopińska-Posłuszny W; Hołojda J; Kopińska A; Hus I; Rybka J; Wołowiec D; Kwiatkowski J; Hałaburda K; Smolewski P; Giebel S; Wiktor-Jędrzejczak W
    Hematol Oncol; 2019 Oct; 37(4):383-391. PubMed ID: 31026087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Veterans with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) have a markedly increased rate of second malignancy, which is the most common cause of death.
    Kyasa MJ; Hazlett L; Parrish RS; Schichman SA; Zent CS
    Leuk Lymphoma; 2004 Mar; 45(3):507-13. PubMed ID: 15160912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
    Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
    Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment patterns in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma post covalent Bruton tyrosine kinase inhibitor treatment: a Japanese claims database study.
    Maruyama D; Wang C; Tanizawa Y; Cai Z; Huang Y; Tajimi M; Kusumoto S
    J Clin Exp Hematop; 2023; 63(4):219-229. PubMed ID: 38148012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
    Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
    J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin transformation of chronic lymphocytic leukemia: the M. D. Anderson Cancer Center experience.
    Tsimberidou AM; O'Brien S; Kantarjian HM; Koller C; Hagemeister FB; Fayad L; Lerner S; Bueso-Ramos CE; Keating MJ
    Cancer; 2006 Sep; 107(6):1294-302. PubMed ID: 16902984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in three major NHL subtypes: descriptive epidemiology.
    Li Y; Wang Y; Wang Z; Yi D; Ma S
    Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Composite Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia and Follicular Lymphoma: A Clinicopathological Study of Six Cases.
    Jelloul FZ; Chen QH; Yang T; Haghi N; Brody J; Zhang X; Sheikh-Fayyaz S
    Int J Surg Pathol; 2018 Apr; 26(2):135-144. PubMed ID: 29069998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
    Mauro FR; Galieni P; Tedeschi A; Laurenti L; Del Poeta G; Reda G; Motta M; Gozzetti A; Murru R; Caputo MD; Campanelli M; Frustaci AM; Innocenti I; Raponi S; Guarini A; Morabito F; Foà R; Gentile M
    Am J Hematol; 2017 Jun; 92(6):529-535. PubMed ID: 28295527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease.
    Tees MT; Flinn IW
    Expert Rev Hematol; 2017 Feb; 10(2):137-146. PubMed ID: 27936980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology, treatment patterns and survival of chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL) in Taiwan, 2006-2015.
    Ko BS; Chen LJ; Huang HH; Chen HM; Hsiao FY
    Int J Clin Pract; 2021 Aug; 75(8):e14258. PubMed ID: 33884738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
    Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
    Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral T-cell lymphomas with cytotoxic phenotype in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Boyer DF; Lindeman NI; Harris NL; Ferry JA
    Am J Surg Pathol; 2014 Feb; 38(2):279-88. PubMed ID: 24418862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia cutis coexisting with dermatofibroma as the initial presentation of B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Maughan C; Kolker S; Markus B; Young J
    Am J Dermatopathol; 2014 Jan; 36(1):e14-5. PubMed ID: 23974225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Amador-Ortiz C; Goolsby CL; Peterson LC; Wolniak KL; McLaughlin JL; Gao J; Chen YH
    Am J Clin Pathol; 2015 Feb; 143(2):214-22. PubMed ID: 25596247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.